LumiThera's LT-300 Device for the Treatment of Advanced Dry Macular Degeneration Obtains CE Marking

26 June 2018

LumiThera Inc., a commercial medical device company dedicated to the development of non-invasive photobiomodulation (PBM) therapies for eye diseases and disorders, has announced that its LT- 300 Li